14.14
price up icon0.78%   0.11
pre-market  시장 영업 전:  13.85   -0.29   -2.05%
loading
전일 마감가:
$14.03
열려 있는:
$14.27
하루 거래량:
665.48K
Relative Volume:
0.96
시가총액:
$1.29B
수익:
$247.00M
순이익/손실:
$-249.00M
주가수익비율:
-4.5761
EPS:
-3.09
순현금흐름:
$-267.00M
1주 성능:
+2.32%
1개월 성능:
-8.77%
6개월 성능:
-0.98%
1년 성능:
-7.82%
1일 변동 폭
Value
$13.99
$14.36
1주일 범위
Value
$13.81
$14.52
52주 변동 폭
Value
$13.51
$20.31

Arcus Biosciences Inc Stock (RCUS) Company Profile

Name
명칭
Arcus Biosciences Inc
Name
전화
(510) 694-6200
Name
주소
3928 POINT EDEN WAY, HAYWARD, CA
Name
직원
577
Name
트위터
@arcusbio
Name
다음 수익 날짜
2024-12-06
Name
최신 SEC 제출 서류
Name
RCUS's Discussions on Twitter

RCUS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RCUS
Arcus Biosciences Inc
14.14 1.29B 247.00M -249.00M -267.00M -3.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-10-21 개시 H.C. Wainwright Neutral
2024-10-08 개시 Wells Fargo Overweight
2022-11-18 개시 BofA Securities Neutral
2022-10-11 개시 Morgan Stanley Overweight
2021-10-15 재개 BTIG Research Buy
2020-11-24 개시 Berenberg Buy
2020-11-23 개시 Evercore ISI Outperform
2020-04-03 개시 Cantor Fitzgerald Overweight
2020-03-04 개시 Barclays Overweight
2019-11-12 개시 SunTrust Buy
2019-09-27 개시 Mizuho Buy
2019-05-24 재개 Citigroup Buy
2018-10-09 개시 Wedbush Outperform
2018-04-09 개시 Citigroup Buy
2018-04-09 개시 Goldman Neutral
2018-04-09 개시 Leerink Partners Outperform
모두보기

Arcus Biosciences Inc 주식(RCUS)의 최신 뉴스

pulisher
Jan 21, 2025

Arcus Biosciences Appoints Richard Markus, M.D., Ph.D. as Chief Medical Officer - BioSpace

Jan 21, 2025
pulisher
Jan 21, 2025

Arcus Biosciences appoints new Chief Medical Officer - Investing.com

Jan 21, 2025
pulisher
Jan 21, 2025

Arcus Biosciences appoints new Chief Medical Officer By Investing.com - Investing.com UK

Jan 21, 2025
pulisher
Jan 21, 2025

Arcus Biosciences Announces New Chief Medical Officer - TipRanks

Jan 21, 2025
pulisher
Jan 21, 2025

Arcus Biosciences Names Amgen Veteran Richard Markus as CMO to Lead Expanding Phase 3 Pipeline - StockTitan

Jan 21, 2025
pulisher
Jan 21, 2025

Arcus Biosciences, Inc. (NYSE:RCUS) Given Average Rating of "Buy" by Analysts - MarketBeat

Jan 21, 2025
pulisher
Jan 21, 2025

Arcus Biosciences, Inc. (NYSE:RCUS) Given Average Rating of “Buy” by Analysts - Defense World

Jan 21, 2025
pulisher
Jan 19, 2025

Wells Fargo Initiates Coverage of Arcus Biosciences (RCUS) with Overweight Recommendation - MSN

Jan 19, 2025
pulisher
Jan 17, 2025

Undercovered Dozen: Lincoln National, Whitecap Resources, NMI Holdings, Healwell AI + - Seeking Alpha

Jan 17, 2025
pulisher
Jan 17, 2025

How the (RCUS) price action is used to our Advantage - Stock Traders Daily

Jan 17, 2025
pulisher
Jan 14, 2025

Arcus Biosciences: Many Important Oncology Catalysts Coming Up In 2025 - Seeking Alpha

Jan 14, 2025
pulisher
Jan 13, 2025

Arcus Biosciences stock hits 52-week low at $13.51 By Investing.com - Investing.com Canada

Jan 13, 2025
pulisher
Jan 13, 2025

Arcus Biosciences (NYSE:RCUS) Sets New 52-Week LowTime to Sell? - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

Arcus: Excellent Pipeline And Collaborations, Cash Runway (NYSE:RCUS) - Seeking Alpha

Jan 13, 2025
pulisher
Jan 11, 2025

Arcus Biosciences (NYSE:RCUS investor three-year losses grow to 60% as the stock sheds US$79m this past week - Simply Wall St

Jan 11, 2025
pulisher
Jan 03, 2025

Robert C. Goeltz II Sells 3,594 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) Stock - MarketBeat

Jan 03, 2025
pulisher
Jan 03, 2025

Principal Financial Group Inc. Sells 18,777 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jan 03, 2025
pulisher
Dec 29, 2024

Geode Capital Management LLC Has $18.69 Million Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Dec 29, 2024
pulisher
Dec 28, 2024

Barclays PLC Grows Position in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Dec 28, 2024
pulisher
Dec 28, 2024

Arcus Biosciences, Inc. (NYSE:RCUS) Shares Purchased by Barclays PLC - MarketBeat

Dec 28, 2024
pulisher
Dec 27, 2024

(RCUS) Trading Report - Stock Traders Daily

Dec 27, 2024
pulisher
Dec 27, 2024

Arcus Biosciences, Inc. (NYSE:RCUS) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Dec 27, 2024
pulisher
Dec 27, 2024

Arcus Biosciences, Inc. (NYSE:RCUS) Given Consensus Rating of “Buy” by Brokerages - Defense World

Dec 27, 2024
pulisher
Dec 24, 2024

Arcus Biosciences Grants Stock Options, RSUs to New Employees Under Inducement Plan - StockTitan

Dec 24, 2024
pulisher
Dec 20, 2024

Shareholders in Arcus Biosciences (NYSE:RCUS) have lost 65%, as stock drops 9.9% this past week - Yahoo Finance

Dec 20, 2024
pulisher
Dec 20, 2024

Jane Street Group LLC Boosts Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

State Street Corp Lowers Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat

Dec 20, 2024
pulisher
Dec 19, 2024

Arcus Biosciences to Present at J.P. Morgan Healthcare Conference 2025Key Oncology Updates Expected - StockTitan

Dec 19, 2024
pulisher
Dec 19, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 26,966 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Dec 19, 2024
pulisher
Dec 18, 2024

BNP Paribas Financial Markets Has $173,000 Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Dec 18, 2024
pulisher
Dec 16, 2024

(RCUS) Trading Advice - Stock Traders Daily

Dec 16, 2024
pulisher
Dec 14, 2024

Arcus Biosciences' SWOT analysis: stock outlook amid HIF2alpha and TIGIT progress - Investing.com

Dec 14, 2024
pulisher
Dec 12, 2024

Estimating The Intrinsic Value Of Arcus Biosciences, Inc. (NYSE:RCUS) - Simply Wall St

Dec 12, 2024
pulisher
Dec 11, 2024

Charles Schwab Investment Management Inc. Has $8.67 Million Stock Position in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat

Dec 11, 2024
pulisher
Dec 10, 2024

Arcus Biosciences Announces New Employment Inducement Grants - Marketscreener.com

Dec 10, 2024
pulisher
Dec 10, 2024

Arcus Biosciences Awards New Employee Equity Grants Under Inducement Plan - StockTitan

Dec 10, 2024
pulisher
Dec 07, 2024

Fmr LLC Boosts Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat

Dec 07, 2024
pulisher
Dec 06, 2024

Point72 Asset Management L.P. Increases Stake in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat

Dec 06, 2024
pulisher
Dec 06, 2024

(RCUS) Investment Analysis and Advice - Stock Traders Daily

Dec 06, 2024
pulisher
Dec 04, 2024

Arcus Biosciences' chief accounting officer sells $3,079 in stock - Investing.com

Dec 04, 2024
pulisher
Dec 04, 2024

Arcus Biosciences' chief accounting officer sells $3,079 in stock By Investing.com - Investing.com Canada

Dec 04, 2024
pulisher
Dec 04, 2024

Parkman Healthcare Partners LLC Acquires 610,219 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat

Dec 04, 2024
pulisher
Dec 03, 2024

Arcus Biosciences Grants New Employee Stock Options and RSUs in Latest Inducement Awards - StockTitan

Dec 03, 2024
pulisher
Dec 03, 2024

Walleye Capital LLC Makes New Investment in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat

Dec 03, 2024
pulisher
Dec 02, 2024

Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend - Benzinga

Dec 02, 2024
pulisher
Nov 29, 2024

Suvretta Capital Management LLC Trims Position in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat

Nov 29, 2024
pulisher
Nov 28, 2024

Algert Global LLC Has $1.73 Million Position in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat

Nov 28, 2024
pulisher
Nov 27, 2024

Arcus up 4% following Merck Welireg kidney cancer data - MSN

Nov 27, 2024
pulisher
Nov 25, 2024

When (RCUS) Moves Investors should Listen - Stock Traders Daily

Nov 25, 2024
pulisher
Nov 24, 2024

BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $14.24 Million Stake in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat

Nov 24, 2024
pulisher
Nov 22, 2024

RCUS (Arcus Biosciences) Cash-to-Debt : 18.78 (As of Sep. 2024) - GuruFocus.com

Nov 22, 2024

Arcus Biosciences Inc (RCUS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
자본화:     |  볼륨(24시간):